© 2026 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement
<< Back To Article
FDA Approves First CRISPR Gene Therapy for Sickle Cell Disease

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*

1 Comments

Clover lilac

The FDA’s approval of the first CRISPR gene therapy for sickle cell disease marks a groundbreaking moment in medical science. This innovative beverly hills psychiatrist approach offers hope for patients by targeting the genetic mutation at its root, potentially transforming treatment and providing a long-awaited cure for a debilitating condition.

February 17, 2025

Hot topics

Breast Cancer
Lung Cancer
Liver Cancer
Prostate Cancer
Cancer Treatment
FIT test, colon cancer screening
Cancer Screening
Ovarian Cancer
Blood Cancers - Leukemia/Lymphoma/Multiple Myeloma

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.